News & Updates

How safe is sacubitril-valsartan plus spironolactone for ADHF?
How safe is sacubitril-valsartan plus spironolactone for ADHF?
04 Jan 2025

Initiation of sacubitril-valsartan with spironolactone during hospitalization for acute decompensated heart failure (ADHF) does not result in more adverse drug reactions (ADRs), reports a study. However, patients on this regimen tend to develop hyperkalemia.

How safe is sacubitril-valsartan plus spironolactone for ADHF?
04 Jan 2025
NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
30 Dec 2024 byChristina Lau

Elevated N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels independently predict cardiorenal complications in Chinese patients with type 2 diabetes (T2D) and can be utilized as a clinical prognostic biomarker for risk stratification to enable more intensive organ-protective treatment in those at risk, a study involving 1,993 patients enrolled in the Hong Kong Diabetes Biobank has shown.

NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
30 Dec 2024